Cargando…

Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy

AIMS: This study aims at evaluating the metrics of glycemic control in people with type 1 diabetes using the hybrid closed loop (HCL) system during the COVID-19 lockdown. METHODS: This is a retrospective study of thirty adults with type 1 diabetes using HCL and followed with telemedicine at an Itali...

Descripción completa

Detalles Bibliográficos
Autores principales: Longo, Miriam, Caruso, Paola, Petrizzo, Michela, Castaldo, Filomena, Sarnataro, Annalisa, Gicchino, Maurizio, Bellastella, Giuseppe, Esposito, Katherine, Maiorino, Maria Ida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486201/
https://www.ncbi.nlm.nih.gov/pubmed/32926958
http://dx.doi.org/10.1016/j.diabres.2020.108440
_version_ 1783581299659767808
author Longo, Miriam
Caruso, Paola
Petrizzo, Michela
Castaldo, Filomena
Sarnataro, Annalisa
Gicchino, Maurizio
Bellastella, Giuseppe
Esposito, Katherine
Maiorino, Maria Ida
author_facet Longo, Miriam
Caruso, Paola
Petrizzo, Michela
Castaldo, Filomena
Sarnataro, Annalisa
Gicchino, Maurizio
Bellastella, Giuseppe
Esposito, Katherine
Maiorino, Maria Ida
author_sort Longo, Miriam
collection PubMed
description AIMS: This study aims at evaluating the metrics of glycemic control in people with type 1 diabetes using the hybrid closed loop (HCL) system during the COVID-19 lockdown. METHODS: This is a retrospective study of thirty adults with type 1 diabetes using HCL and followed with telemedicine at an Italian University Hospital. Data on metrics of glucose control were collected at different times: two weeks before the lockdown (Time 0), first two weeks of lockdown (Time 1), last two weeks of lockdown (Time 2) and first two weeks after the lockdown (Time 3). The primary endpoint was the change in glucose management indicator (GMI) across the different time points. RESULTS: GMI did not worsen over time (Time 1 vs Time 3, 7% vs 6.9%, P < 0.05), whereas a reduction of mean glucose (P = 0.004) and indices of glucose variability was observed. Time in range (TIR) significantly increased (68.5% vs 73.5%, P = 0.012), and time above range (TAR) level 2 (251–400 mg/dL) significantly decreased (P = 0.002). The improvement of TIR and glucose variability was mainly observed in participants < 35 years. CONCLUSIONS: Adults with type 1 diabetes using HCL showed a significant improvement of most of the metrics of glucose control during the COVID-19 lockdown.
format Online
Article
Text
id pubmed-7486201
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-74862012020-09-14 Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy Longo, Miriam Caruso, Paola Petrizzo, Michela Castaldo, Filomena Sarnataro, Annalisa Gicchino, Maurizio Bellastella, Giuseppe Esposito, Katherine Maiorino, Maria Ida Diabetes Res Clin Pract Article AIMS: This study aims at evaluating the metrics of glycemic control in people with type 1 diabetes using the hybrid closed loop (HCL) system during the COVID-19 lockdown. METHODS: This is a retrospective study of thirty adults with type 1 diabetes using HCL and followed with telemedicine at an Italian University Hospital. Data on metrics of glucose control were collected at different times: two weeks before the lockdown (Time 0), first two weeks of lockdown (Time 1), last two weeks of lockdown (Time 2) and first two weeks after the lockdown (Time 3). The primary endpoint was the change in glucose management indicator (GMI) across the different time points. RESULTS: GMI did not worsen over time (Time 1 vs Time 3, 7% vs 6.9%, P < 0.05), whereas a reduction of mean glucose (P = 0.004) and indices of glucose variability was observed. Time in range (TIR) significantly increased (68.5% vs 73.5%, P = 0.012), and time above range (TAR) level 2 (251–400 mg/dL) significantly decreased (P = 0.002). The improvement of TIR and glucose variability was mainly observed in participants < 35 years. CONCLUSIONS: Adults with type 1 diabetes using HCL showed a significant improvement of most of the metrics of glucose control during the COVID-19 lockdown. Elsevier B.V. 2020-11 2020-09-12 /pmc/articles/PMC7486201/ /pubmed/32926958 http://dx.doi.org/10.1016/j.diabres.2020.108440 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Longo, Miriam
Caruso, Paola
Petrizzo, Michela
Castaldo, Filomena
Sarnataro, Annalisa
Gicchino, Maurizio
Bellastella, Giuseppe
Esposito, Katherine
Maiorino, Maria Ida
Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
title Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
title_full Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
title_fullStr Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
title_full_unstemmed Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
title_short Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
title_sort glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the covid-19 pandemic in italy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486201/
https://www.ncbi.nlm.nih.gov/pubmed/32926958
http://dx.doi.org/10.1016/j.diabres.2020.108440
work_keys_str_mv AT longomiriam glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly
AT carusopaola glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly
AT petrizzomichela glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly
AT castaldofilomena glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly
AT sarnataroannalisa glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly
AT gicchinomaurizio glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly
AT bellastellagiuseppe glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly
AT espositokatherine glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly
AT maiorinomariaida glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly